NCT02129192 - Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg (T80/A5/H12.5 mg) Fixed-dose Combination (FDC) Tablet and T80/H12.5 mg Tab and A5 mg (Encap A2.5 mg Tab x2) Concomitant Use | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

September 30, 2014

Conditions

Healthy

Interventions

DRUG

Amlodipine 5mg capsule

DRUG

T80/H12.5 mg FDC tablet

Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg FDC tablet

DRUG

T80/A5/H12.5 mg FDC tablet

Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg FDC tablet

Trial Locations (1)

Boehringer Ingelheim Investigational Site, Tokyo, Hachioji